デフォルト表紙
市場調査レポート
商品コード
1738849

低侵襲手術の世界市場規模:手術タイプ別、製品タイプ別、用途別、地域範囲別および予測

Global Minimally Invasive Surgery Market Size By Type of Surgery, By Product Type, By Application, By Geographic Scope And Forecast


出版日
ページ情報
英文 202 Pages
納期
2~3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.90円
低侵襲手術の世界市場規模:手術タイプ別、製品タイプ別、用途別、地域範囲別および予測
出版日: 2025年05月06日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

低侵襲手術(MIS)の市場規模と予測

低侵襲手術の市場規模は、2024年に224億米ドルと評価され、2026年から2032年にかけて10.5%のCAGRで成長し、2032年には355億米ドルに達すると予測されています。

低侵襲手術(MIS)は、従来の開腹手術と同じ結果を得ようとする手術法であるが、身体への負担は、はるかに少ないです。この方法では、小さな切開、特殊な装置、腹腔鏡や内視鏡などの先端技術を用いることで、外科医は大きな切開を必要とせずに内部の組織を観察し、手術することができます。MISの主な利点は、術後の不快感の軽減、入院期間の短縮、治癒時間の短縮、傷跡の軽減です。

この手術は、一般外科、整形外科、婦人科、泌尿器科、循環器科など、さまざまな診療科で応用されています。MIS技術で行われる一般的な治療には、腹腔鏡下胆嚢摘出術(胆嚢摘出術)、関節鏡下関節手術、腹腔鏡下子宮摘出術、内視鏡下副鼻腔手術などがあります。手術機器や画像技術の絶え間ない開発により、MISの可能性は広がり、ますます複雑で繊細な手術が可能になりました。

低侵襲手術(MIS)の将来は、急速な技術向上と患者中心の治療がますます重視されるようになるため、大きな変革が期待されます。最も注目すべき進歩の一つは、ロボット工学と人工知能(AI)を外科手術に取り入れることです。ロボット支援手術はますます一般的になってきており、外科医により高い精度、器用さ、コントロールを提供し、これらはすべて小切開で困難な処置を完了するために必要なものです。

低侵襲手術の世界市場力学

世界の低侵襲手術市場を形成している主な市場力学は以下の通り:

主な市場促進要因

患者の利益と転帰:MISを使用する主な理由の一つは、開腹手術に比べて術後の痛みが少なく、感染症のリスクが低く、入院期間が短く、回復が早いことです。これらの利点は、患者さんの満足度と全体的な治療成績の向上に役立ちます。腹腔鏡下胆嚢摘出術(胆嚢摘出術)や低侵襲心臓手術などの治療では、患者の周辺組織への外傷が少ないため、回復が早く、通常の活動に戻ることができます。

技術の進歩:医療技術の急速な向上がMISの成長に大きく貢献しています。高解像度カメラ、小型手術器具、ロボット支援手術システム(ダ・ヴィンチ・サージカル・システムなど)、高度な画像技術(腹腔鏡超音波や術中MRIなど)により、外科医は小切開で複雑な手技をより正確かつ制御しやすく行うことができるようになりました。

ヘルスケアコストの削減:低侵襲手術は、ヘルスケアシステムにとっても患者にとっても、コスト削減の可能性を示しています。MIS技術に関連する初期設備費は高額になる可能性があるが、最終的な費用対効果は、入院期間の短縮、手術合併症の減少、経過観察の回数減少、治癒期間の短縮によって実証されています。長期的には、これらの変数がヘルスケアコストの削減と資源利用の改善に貢献します。

主な課題

技術的専門知識とトレーニングの必要性:MISの重要な問題のひとつは、必要な技術や能力を習得するのに必要な学習曲線が高いことです。外科医は、内視鏡機器やロボット機器を使って小さな切開創を操作するために、特別な訓練と技術を必要とします。MISにおける技術や手と目の協調は、通常の開腹手術で必要とされるものとは異なることが多いです。

機器と器具のコスト:専門機器や器具のコストが高いため、MISの導入には限界があります。内視鏡カメラ、腹腔鏡機器、ロボットシステム、その他MISで利用される画期的な技術は、入手、維持、アップグレードにコストがかかります。ヘルスケアや医療施設はこれらの技術を手に入れるために多大な努力をしなければならず、財源を圧迫しかねないです。

合併症のリスクと学習曲線の影響:MISは従来の開腹手術に比べ合併症が少なく、回復も早いが、MISの導入に危険がないわけではないです。MIS手術の実施に伴う学習曲線は、不慮の臓器損傷、出血、開腹手術への転換などの術中問題の増加につながるかもしれないです。MISのキャリアをスタートさせた外科医は、小切開による解剖学的評価や予期せぬ術中所見の管理を適切に行うことの難しさに直面するかもしれないです。

主な動向:

適応拡大:当初は盲腸や胆嚢摘出などの手術に限られていたMISは、現在では幅広い外科専門分野を含むようになりました。低侵襲心臓手術(MICS)、低侵襲脊椎手術、ロボット支援による婦人科手術などの複雑な治療は、すでに標準的な診療となっています。明確な解剖学的部位に的を絞った特殊な機器や手技の開発により、MISの有用性は幅広い医療疾患に広がっています。

患者の転帰の改善:患者の治療成績の向上はMISの特徴であり、引き続き採用の原動力となっています。周辺組織への外傷の減少、術後の痛みの軽減、回復時間の短縮はすべて、入院期間の短縮と医療費の削減に貢献しています。開腹手術に比べ、MISを受けた患者は傷跡が残りにくく、創感染症のリスクも低いです。

トレーニングと教育MISのアプローチが進歩するにつれ、トレーニングと教育が重要な焦点となっています。外科医は低侵襲手技をマスターし、技術革新を巧みに管理するための特別なトレーニングを必要としています。シミュレーションに基づいたトレーニングプログラムやバーチャルリアリティ(VR)シミュレーターは、外科医が患者に手技を行う前に、管理された環境で実地経験を積むためにますます使用されるようになってきています。

目次

第1章 イントロダクション

  • 市場の定義
  • 市場セグメンテーション
  • 調査手法

第2章 エグゼクティブサマリー

  • 主な調査結果
  • 市場概要
  • 市場ハイライト

第3章 市場概要

  • 市場規模と成長の可能性
  • 市場動向
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • ポーターのファイブフォース分析

第4章 低侵襲手術(MIS)市場:手術タイプ別

  • 腹腔鏡手術
  • ロボット手術
  • 内視鏡手術
  • 胸腔鏡手術

第5章 低侵襲手術(MIS)市場:製品タイプ別

  • 手術器具
  • ロボットシステム
  • 可視化システム
  • 付属品と消耗品

第6章 低侵襲手術(MIS)市場:用途別

  • 消化器外科
  • 心臓外科
  • 整形外科
  • 婦人科手術

第7章 地域別分析

  • 北米
  • 米国
  • カナダ
  • メキシコ
  • 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • チリ
  • 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第8章 市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • COVID-19の市場への影響

第9章 競合情勢

  • 主要企業
  • 市場シェア分析

第10章 企業プロファイル

  • Medtronic plc(Ireland)
  • Johnson & Johnson(US)
  • Stryker Corporation(US)
  • Abbott Laboratories(US)
  • Boston Scientific Corporation(US)
  • Siemens Healthineers AG(Germany)
  • Philips(Netherlands)
  • GE Healthcare(US)
  • Smith & Nephew plc(UK)
  • Zimmer Biomet Holdings, Inc.(US)
  • Olympus Corporation(Japan)
  • Intuitive Surgical Inc.(US)(Focuses on robotic-assisted surgery)
  • CONMED Corporation(US)
  • B. Braun Melsungen AG(Germany)

第11章 市場の展望と機会

  • 新興技術
  • 今後の市場動向
  • 投資機会

第12章 付録

  • 略語リスト
  • 出典と参考文献
目次
Product Code: 40466

Minimally Invasive Surgery (MIS) Market Size And Forecast

Minimally Invasive Surgery Market size was valued at USD 22.4 Billion in 2024 and is projected to reach USD 35.5 Billion by 2032, growing at a CAGR of 10.5% from 2026 to 2032.

Minimally invasive surgery (MIS) is a surgical method that tries to produce the same results as traditional open surgery but causing much less stress to the body. This method employs small incisions, specialized devices, and advanced technology such as laparoscopes and endoscopes allowing surgeons to observe and operate on interior tissues without the need for big incisions. The primary benefits of MIS are decreased postoperative discomfort, shorter hospital stays, faster healing times, and less scarring.

This surgery has numerous applications in a variety of medical specialties including general surgery, orthopedics, gynecology, urology, and cardiology. Common treatments performed with MIS techniques include laparoscopic cholecystectomy (gallbladder removal), arthroscopic joint surgeries, laparoscopic hysterectomy, and endoscopic sinus surgery. Continuous developments in surgical equipment and imaging technologies have broadened the possibilities for MIS allowing for increasingly intricate and delicate procedures.

The future of minimally invasive surgery (MIS) promises to be transformative because of rapid technological improvements and an increasing emphasis on patient-centered care. One of the most notable advancements is the incorporation of robotics and artificial intelligence (AI) into surgical procedures. Robotic-assisted operations are becoming increasingly common providing surgeons with more precision, dexterity, and control all of which are necessary for completing difficult procedures through small incisions.

Global Minimally Invasive Surgery Market Dynamics

The key market dynamics that are shaping the global minimally invasive surgery market include:

Key Market Drivers:

Patient Benefits and Outcomes: One of the key reasons for using MIS is that it provides patients with less postoperative pain, a lower risk of infection, shorter hospital stays, and faster recovery times than open operations. These benefits help to increase patient satisfaction and overall outcomes. Patients undergo less trauma to surrounding tissues during treatments such as laparoscopic cholecystectomy (gallbladder removal) or minimally invasive cardiac surgeries resulting in faster recovery and return to normal activities.

Technological Advancements: Rapid improvements in medical technology have contributed significantly to the growth of MIS. High-definition cameras, miniature surgical instruments, robotic-assisted surgery systems (such as the da Vinci Surgical System), and advanced imaging techniques (such as laparoscopic ultrasound and intraoperative MRI) have allowed surgeons to perform complex procedures more precisely and controllably through small incisions.

Reduced Healthcare Costs: Minimally invasive surgery has shown potential cost reductions for healthcare systems and patients alike. While the initial equipment expenses connected with MIS technology can be high, the eventual cost-effectiveness is demonstrated by shorter hospital stays, less surgical complications, fewer follow-up visits, and faster healing durations. In the long run, these variables contribute to lower healthcare costs and better resource utilization.

Key Challenge:

Technical Expertise and Training Requirements: One of the key problems of MIS is the high learning curve required to master the requisite techniques and abilities. Surgeons need specific training and skill to maneuver through smaller incisions with endoscopic equipment or robotic devices. Skill and hand-eye coordination in MIS are frequently different from those necessary in regular open surgery.

Equipment and Instrumentation Costs: The high cost of specialist equipment and instrumentation limits the deployment of MIS. Endoscopic cameras, laparoscopic equipment, robotic systems, and other technological breakthroughs utilized in MIS are costly to acquire, maintain, and upgrade. Hospitals and healthcare facilities must make large efforts to obtain these technology which might strain financial resources.

Complication Risk and Learning Curve Impact: Although MIS has lower complications and faster recovery periods than traditional open surgery, the move is not without dangers. The learning curve associated with implementing MIS procedures might lead to an increase in intraoperative problems such as unintentional organ injury, hemorrhage, or conversion to open surgery. Surgeons beginning their MIS careers may face difficulties in appropriately assessing anatomy and managing unexpected intraoperative findings through small incisions.

Key Trends:

Indication Expansion: Originally limited to operations such as appendectomies and cholecystectomies, MIS has now grown to include a wide range of surgical specialties. Complex treatments such as minimally invasive heart surgery (MICS), minimally invasive spine surgery, and robotic-assisted gynecological surgeries are already standard practice. The development of specialized devices and techniques targeted to distinct anatomical sites has increased the usefulness of MIS to a wide range of medical disorders.

Improved Patient Outcomes: Improved patient outcomes are a defining feature of MIS and continue to drive adoption. Reduced trauma to surrounding tissues, less postoperative pain, and faster recovery times all contribute to shorter hospital stays and cheaper healthcare expenditures. Compared to open operations, patients who undergo MIS frequently have less scarring and a lower risk of wound infections.

Training and Education: As MIS approaches advance, training and education have become major focal points. Surgeons require specific training to master minimally invasive techniques and skillfully manage technological innovations. Simulation-based training programs and virtual reality (VR) simulators are increasingly being used to give surgeons hands-on experience in a controlled environment prior to performing procedures on patients.

Global Minimally Invasive Surgery Market Regional Analysis

North America

North America leads the global minimally invasive surgeries (MIS) market which is seeing strong growth due to a number of major drivers. One critical issue is the growing frequency of chronic diseases throughout the region which range from cardiovascular disorders to orthopedic ailments and malignancies. As chronic illnesses become increasingly common, there is a greater desire for improved medical solutions that provide less invasive treatment choices. Minimally invasive operations which have smaller incisions, shorter recovery times, and a lower risk of problems than standard open surgeries are growing popular among both patients and healthcare practitioners.

The extensive use of minimally invasive operations in North America can be traced to a gradual shift in medical practice and patient preferences. Healthcare systems in the region are increasingly emphasizing the benefits of MIS which include shorter hospital stays, faster recovery times, and better cosmetic outcomes. These benefits not only improve patient satisfaction but also lead to cost savings in the healthcare system.

Furthermore, advances in surgical instruments, imaging technology, and robotics have greatly increased the scope and precision of MIS treatments making them appropriate for a wider range of medical disorders.

Europe

The European market for minimally invasive operations is expanding rapidly owing to considerable government backing aimed at promoting wider use throughout the area. European governments are actively encouraging minimally invasive procedures because of its multiple advantages such as faster recovery times, fewer risk of problems, and shorter hospital stays. These methods which use advanced technologies and techniques to perform surgeries through small incisions rather than traditional open surgery are becoming increasingly popular among healthcare providers and patients alike.

European government's assistance includes measures to improve healthcare professional training in minimally invasive treatments, money for medical device research and development, and incentives for hospitals to invest in cutting-edge surgical equipment. These efforts are intended to improve healthcare outcomes, optimize resource use within healthcare systems, and lower overall healthcare expenditures. As a result, the European market for minimally invasive operations is expected to grow further with advances in surgical instruments, imaging technology, and surgical robotics driving additional progress.

Global Minimally Invasive Surgery Market: Segmentation Analysis

The Global Minimally Invasive Surgery Market is segmented based on Type of Surgery, Applications, Product Type, and Geography.

Minimally Invasive Surgery Market, By Type of Surgery

  • Surgical Instruments
  • Robotics Systems
  • Visualization Systems
  • Accessories and Consumables

Based on Type of Surgery, the Global Minimally Invasive Surgery Market is bifurcated into Surgical Instruments, Robotics Systems, Visualization Systems, Accessories and Consumables. Robotic surgery is emerging as the dominant type within the minimally invasive surgery (MIS) market. Robotic systems offer surgeons enhanced precision, dexterity, and 3D visualization capabilities which are crucial for performing complex procedures with greater accuracy compared to traditional methods. These systems enable minimally invasive surgeries across various specialties including urology, gynecology, and general surgery, thereby expanding their applicability and adoption. Furthermore, robotic surgery platforms continue to evolve with advancements in artificial intelligence and machine learning promising even greater surgical outcomes and efficiency.

Minimally Invasive Surgery Market, By Application

  • Gastrointestinal Surgery
  • Cardiothoracic Surgery
  • Orthopedic Surgery
  • Gynecological Surgery

Based on Application, the Global Minimally Invasive Surgery Market is bifurcated into Gastrointestinal Surgery, Cardiothoracic Surgery, Orthopedic Surgery, and Gynecological Surgery. Among the listed applications, minimally invasive surgery (MIS) in orthopedic surgery stands out as particularly dominant. This dominance can be attributed to several factors. Advancements in arthroscopic techniques have revolutionized the treatment of orthopedic conditions like knee injuries, shoulder problems, and hip disorders. These procedures offer patients reduced recovery times, minimal scarring, and lower risks of infection compared to traditional open surgeries. Moreover, the aging population and increasing sports-related injuries have fueled the demand for orthopedic interventions that offer quicker rehabilitation and less post-operative pain. Overall, the combination of clinical effectiveness, patient preference for quicker recovery, and ongoing technological innovation positions orthopedic MIS as the dominant application within the broader MIS market landscape.

Minimally Invasive Surgery Market, By Product Type

  • Surgical Instruments
  • Robotics Systems
  • Visualization Systems
  • Accessories and Consumables

Based on Product Type, the Global Minimally Invasive Surgery Market is bifurcated into Surgical Instruments, Robotics Systems, Visualization Systems, Accessories and Consumables. In the minimally invasive surgery (MIS) market, surgical instruments dominate due to their essential role in performing precise and controlled procedures. These instruments including laparoscopic graspers, scissors, dissectors, and trocars are fundamental for manipulating tissues and organs through small incisions minimizing trauma and promoting quicker recovery times for patients. Surgical instruments are widely used across various specialties such as general surgery, gynecology, urology, and orthopedics contributing significantly to the overall adoption of minimally invasive techniques. Their versatility coupled with advancements in design and materials continually enhances surgical outcomes and patient safety.

Minimally Invasive Surgery Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on Geography, the Global Minimally Invasive Surgery Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. Among the regions mentioned, North America stands out as dominant in the minimally invasive surgery (MIS) market. The United States leads due to advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on technological innovation. The market in the US benefits from extensive research and development activities, favorable reimbursement policies, and a large patient pool opting for minimally invasive procedures. Overall, North America's dominance in the MIS market is bolstered by its robust healthcare system, technological advancements, and proactive government support.

Key Players

The "Global Minimally Invasive Surgery Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic plc, Johnson & Johnson, Stryker Corporation, Abbott Laboratories, Boston Scientific Corporation, Siemens Healthineers AG, Philips, GE Healthcare, Smith & Nephew plc, Zimmer Biomet Holdings, Inc., Olympus Corporation, Intuitive Surgical Inc., CONMED Corporation, and B. Braun Melsungen AG.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Minimally Invasive Surgery Market Key Developments

  • In June 2022, Boston Scientific agreed to buy a controlling stake in M.I.Tech, a manufacturer and distributor of non-vascular metal stents used in endoscopic and urologic operations, from South Korea's Synergy Innovation. Boston Scientific offered about KRW 14,500 (about USD 11) per M.I.Tech share, for a total price of KRW 291.2, or around USD 230 million.
  • In January 2024, PENTAX Medical received CE certification for its PENTAX Medical INSPIRA, a new premium video processor, and the i20c video endoscope series. The new video processor retains compatibility with PENTAX Medical's most recent endoscope models while also setting new standards with the new i20c video endoscope generation.

TABLE OF CONTENTS

1. Introduction

  • Market Definition
  • Market Segmentation
  • Research Methodology

2. Executive Summary

  • Key Findings
  • Market Overview
  • Market Highlights

3. Market Overview

  • Market Size and Growth Potential
  • Market Trends
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Porter's Five Forces Analysis

4. Minimally Invasive Surgery (MIS) Market , By Type of Surgery

  • Laparoscopic Surgery
  • Robotic Surgery
  • Endoscopic Surgery
  • Thoracoscopic Surgery

5. Minimally Invasive Surgery (MIS) Market, By Product Type

  • Surgical Instruments
  • Robotics Systems
  • Visualization Systems
  • Accessories and Consumables

6. Minimally Invasive Surgery (MIS) Market, By Application

  • Gastrointestinal Surgery
  • Cardiothoracic Surgery
  • Orthopedic Surgery
  • Gynecological Surgery

7. Regional Analysis

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

8. Market Dynamics

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Impact of COVID-19 on the Market

9. Competitive Landscape

  • Key Players
  • Market Share Analysis

10. Company Profiles

  • Medtronic plc (Ireland)
  • Johnson & Johnson (US)
  • Stryker Corporation (US)
  • Abbott Laboratories (US)
  • Boston Scientific Corporation (US)
  • Siemens Healthineers AG (Germany)
  • Philips (Netherlands)
  • GE Healthcare (US)
  • Smith & Nephew plc (UK)
  • Zimmer Biomet Holdings, Inc. (US)
  • Olympus Corporation (Japan)
  • Intuitive Surgical Inc. (US) (Focuses on robotic-assisted surgery)
  • CONMED Corporation (US)
  • B. Braun Melsungen AG (Germany)

11. Market Outlook and Opportunities

  • Emerging Technologies
  • Future Market Trends
  • Investment Opportunities

12. Appendix

  • List of Abbreviations
  • Sources and References